We present experimental evidence for the existence of multiple activator-binding sites in the upstream sequence of the ompC promoter, the expression of which is activated by the positive regulator OmpR in response to the osmolarity of the medium. We also found that a single OmpR-binding site can activate the ompC promoter, providing that the binding site is close and placed stereospecifically with respect to the canonical -35 and -10 regions.
from upstream to nucleotide -95, was well protected against DNase I digestion by the OmpR protein (Fig. 2 , lanes 3 and 4). Although a slight difference was observed, the protection profile was essentially the same as that observed in the wild-type (pCI-0) (Fig. 2, lanes 1 and 2) , namely, the protected region comprised nucleotides -94 to -37. It should be noted that, upon OmpR binding to the region, remarkable enhancement of DNase I digestion was observed at nucleotides -74 and -73. Even in the case of the deletion mutant pCD-78, in which the deletion extended to nucleotide -79, significant protection was observed in the region between nucleotides -70 and -37 (Fig. 2 , lanes 5 and 6), although the protection seems to be less than in the case of pCD-94. The upstream region of the deletion mutant pCD-35, in which nucleotides from -58 to -35 were replaced by a nonspecific linker sequence (9) , was also found to be protected by the OmpR protein, and the protected region comprised nucleotides -101 to -55 (Fig. 2, lanes 7 and 8) . Interestingly, it was further revealed that when the upstream sequence of pCD-7135 (in which nucleotides from -71 to -35 were deleted) was examined, the region between nucleotides -101 and -78 was clearly protected (Fig. 2, lanes 9 and 10). These results are summarized in Fig. 1 We next examined the promoter activities of these deletion mutants of the ompC promoter fused to the lacZ gene. The plasmids listed in Fig. 1 (Fig. 2) . The nucleotides at which enhancement of DNase I digestion was observed (v) are also indicated.
harboring one of the plasmids was then measured (10) after the cells were grown in medium A containing 15% sucrose (7) . Cells harboring plasmid pCD-94 exhibited OmpR-dependent expression of 3-galactosidase activity, while ,B-galactosidase activities expressed in the cells harboring either ,,, X: plasmid pCD-78 or plasmid pCD-35 were significantly reduced (Table 1 ). More importantly, it was revealed that the deletion mutant (pCD-7135) in which only one OmpRbinding site (the most upstream one) is just in front of the -35 and -10 regions of the ompC promoter displayed significant 3-galactosidase activity, which was expressed in an OmpR-dependent manner. The critical question of whether the transcription start site of this particular deletion mutant (pCD-7135) is the same as that of the wild-type ompC promoter then arose. The transcription start site of the mutant promoter was determined by reverse transcriptase mapping (1, 9) . The transcription start site of the deletion mutant was the same as that of the wild-type promoter (Fig.  3, lanes 1 and 2) . Furthermore, the transcription in the case of pCD-7135 appears to be dependent on the OmpR function (Fig. 3, lane 3) . Considering the fact that the deletion mutant in plasmid pCD-78 did not exhibit significant 3-galactosidase activity, the following was suggested. First, the most up- (8, 9) . In this respect, it should be emphasized that the single OmpR-binding site in pCD-7135 is positioned in keeping with such stereospecificity on the DNA helix (Fig.  1) . In conclusion, the results obtained in this study are most easily explained by the fact that the direct interaction between the OmpR protein and RNA polymerase is important in the mechanism underlying the activation of the ompC promoter by the OmpR protein. The multiple OmpR binding observed in the upstream region of the ompC promoter may play a role in the complex mechanism underlying the ompC expression in response to the osmolarity of the medium. This work was supported by grants from the Ministry of Education, Science and Culture of Japan and the Sapporo Bioscience Foundation.
